Related Experiment Videos
Significant clinical differences in primary hyperparathyroidism between patients with and those without concomitant
Toshihiro Masatsugu1, Hiroyuki Yamashita, Shiro Noguchi
1Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Surgery Today
|May 3, 2005
Summary
Patients with primary hyperparathyroidism (pHPT) and thyroid disease were diagnosed earlier. Concomitant thyroid disease impacts pHPT diagnosis, localization, and surgical approach.
Area of Science:
- Endocrinology
- Surgical Oncology
Background:
- Primary hyperparathyroidism (pHPT) is a common endocrine disorder.
- Concurrent thyroid disease can complicate pHPT diagnosis and management.
Purpose of the Study:
- To investigate differences in diagnosis and treatment of pHPT in patients with and without concurrent thyroid disease.
Main Methods:
- 110 patients with pHPT underwent parathyroid localization (ultrasonography, sestamibi scintigraphy) and thyroid examination.
- Clinical, biochemical, localization, and surgical data were compared between groups.
Main Results:
- Asymptomatic hypercalcemia was more prevalent in patients with thyroid disease (88.5% vs 49.0%).
- Patients without thyroid disease had higher serum calcium and lower phosphate levels.
- Parathyroid gland identification was more successful in patients without thyroid disease (US and MIBI).
- Unilateral exploration was more frequent in patients without thyroid disease.
Conclusions:
- pHPT is diagnosed earlier in patients with concurrent thyroid disease.
- Thyroid disease affects parathyroid localization and minimally invasive parathyroidectomy indications.